type 1 diabetes

Trial finds Lilly’s Olumiant could treat type 1 diabetes
Pharmaphorum
Thu, 12/7/23 - 11:00 am
Eli Lilly
olumiant
type 1 diabetes
Vertex Presents Positive, Updated VX-880 Results From Ongoing Phase 1/2 Study in Type 1 Diabetes at the European Association for the Study of Diabetes 59th Annual Meeting
Businesswire
Tue, 10/3/23 - 07:32 pm
Vertex Pharmaceuticals
VX-880
clinical trials
type 1 diabetes
After treatment with semaglutide, people with newly diagnosed type 1 diabetes needed little or no insulin
Medical News Today
Sun, 09/10/23 - 08:03 pm
Novo Nordisk
Ozempic
semaglutide
type 1 diabetes
After First Approval, Experts Point to Barriers in Cell Therapy for Type 1 Diabetes
BioSpace
Thu, 07/13/23 - 10:11 am
CellTrans
Lantidra
type 1 diabetes
cell therapy
Eli Lilly
Siglion Therapeutics
FDA blesses CellTrans' Lantidra, the first cell therapy for Type 1 diabetes
Fierce Pharma
Thu, 06/29/23 - 11:24 am
CellTrans
Lantidra
donislecel
cell therapy
type 1 diabetes
Sernova reports positive interim data for Cell Pouch System
Drug Delivery Business
Tue, 06/27/23 - 10:33 pm
Sernova
Cell Pouch System
type 1 diabetes
Medtech
AstraZeneca Teams Up With Startup Quell in Type 1 Diabetes, IBD Cell Therapy Pact
MedCity News
Fri, 06/9/23 - 11:52 am
AstraZeneca
Quell Therapeutics
type 1 diabetes
IBD
cell therapy
DiogenX SA raises €27.5M in Series A financing for type 1 diabetes work
European Biotechnology
Wed, 05/10/23 - 10:13 am
DiogenX
funding
type 1 diabetes
Sigilon focuses on type 1 diabetes, reduces spend on MPS-1 after letting CMO go
Endpoints
Wed, 03/15/23 - 09:24 pm
Siglion Therapeutics
type 1 diabetes
cell therapy
Canadian royalty investor buys into first-of-its-kind Type 1 diabetes drug
BioPharma Dive
Fri, 03/10/23 - 09:53 am
DRI Healthcare Trust
type 1 diabetes
Macrogenics
Tzield
Vertex's next off-the-shelf diabetes cell therapy follows in predecessor's footsteps to the clinic
Fierce Biotech
Thu, 03/9/23 - 11:24 am
Vertex Pharmaceuticals
type 1 diabetes
cell therapy
VX-264
Medtronic links MiniMed 780G automated insulin delivery to sustained glucose control benefits
Medtech Dive
Mon, 02/27/23 - 10:10 am
Medtronic
devices
Medtech
diabetes
MiniMed 780G
type 1 diabetes
Delaying type 1 diabetes progression: major trial readouts to watch in 2023
Clinical Trials Arena
Mon, 02/20/23 - 12:54 pm
clinical trials
type 1 diabetes
Provention Bio
Tzeild
Diamyd Medical
remygen
Imcyse
IMCY-0098
ProKidney
Panbela begins Phase II trial of type 1 diabetes therapy trial
Clinical Trials Arena
Thu, 01/12/23 - 09:30 pm
Panbela Therapeutics
clinical trials
CPP-1X-T
type 1 diabetes
Diamyd Diabetes Vaccine Study gets Green Light to Resume by the FDA
Xtalks
Thu, 12/15/22 - 11:07 pm
Diamyd Medical
type 1 diabetes
FDA
clinical trials
Diamyd
Lexicon slams FDA over hearing denial following a CRL for its SGLT2 inhibitor candidate
Endpoints
Wed, 11/30/22 - 08:01 pm
Lexicon Pharmaceuticals
FDA
type 1 diabetes
sotagliflozin
FDA lifts partial clinical suspension on Diamyd’s diabetes therapy trial
Clinical Trials Arena
Mon, 11/28/22 - 10:35 am
Diamyd Medical
clinical trials
FDA
type 1 diabetes
Diamyd
FDA greenlights Provention Bio's diabetes drug
Yahoo/Reuters
Fri, 11/18/22 - 10:22 am
Provention Bio
type 1 diabetes
FDA
teplizumab
The global diabetes crisis few are talking about
Stat
Thu, 10/13/22 - 09:42 am
diabetes
type 1 diabetes
patient access
Anticipating FDA Yes, Provention Inks Co-Promotion Deal with Sanofi for T1D Drug
BioSpace
Thu, 10/6/22 - 07:07 pm
Provention Bio
Sanofi
type 1 diabetes
teplizumab

Pages